Elan’s Tysabri drug expected to be back on shelves

The multiple sclerosis drug Tysabri is expected to be put back on the market in the coming months after being withdrawn a year ago due to safety concerns.

The drug, which is manufactured by the Irish pharmaceutical firm Elan, was taken off the shelves just over 12 months ago after three patients undergoing clinical trials developed a rare brain disease.